Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers

Table 2

Demographic details of CHD patients with or without Qi deficiency syndrome.

	Qi deficiency (𝑛=21)	Non-Qi deficiency (𝑛=24)	𝑃 value
Age	59.76±8.61	58.79±7.32	0.685
Gender (male/female)	14/7	19/5	0.344
BMI	25.57±2.49	26.77±6.17	0.750
Years of CHD	3.71±4.16	3.00±3.24	0.419
Diabetes combination	13 (61.9%)	17 (70.8%)	0.526
Hyperlipemia combination	6 (28.6%)	4 (16.7%)	0.338
Use of antiplatelet drugs	21 (100%)	24 (100%)	/
Use of nitrate esters drugs	11 (52.4%)	13 (54.2%)	0.905
Use of statins	14 (66.7%)	19 (79.2%)	0.344
Use of ACEI/ARB	2 (9.5%)	2 (8.3%)	0.889
Use of beta blocker	12 (57.1%)	16 (66.7%)	0.511
Use of calcium channel antagonist	21 (100%)	24 (100%)	/